Latest Moderna Inc (MRNA:NSQ) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Valuation: Moderna, Inc. ; P/E ratio * · EV / Sales * · Yield *. Moderna Company Logo · About us · The Power of mRNA · Research · Responsibility Slide Moderna's RSV vaccine has been approved and recommended for a large. Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). Shareholders have faith in loss-making Moderna (NASDAQ:MRNA) as stock climbs % in past week, taking five-year gain to %. Moderna, Inc. (NASDAQ:MRNA).
The intrinsic value of one MRNA stock under the Base Case scenario is USD. Compared to the current market price of USD, Moderna Inc is Overvalued. Shares can be purchased through a stockbroker of your choice. Who is Moderna's auditor? Moderna, Inc.'s auditor. Key Stats · Market CapB · Shares OutM · 10 Day Average VolumeM · Dividend- · Dividend Yield- · Beta · YTD % Change Looking ahead, we forecast Moderna Inc to be priced at by the end of this quarter and at in one year, according to Trading Economics global macro. Incorporated in , Massachusetts-based Moderna, Inc. is a clinical stage biotechnology company which develops therapeutics and vaccines based on. We're maintaining our $ fair value estimate for no-moat firm Moderna despite disappointing management commentary surrounding the firm's competitiveness. Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Find the latest historical data for Moderna, Inc. Common Stock (MRNA) at sibtennis.ru View historical data in a monthly, bi-annual, or yearly format. About Moderna Inc Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline. There are M shares outstanding in Moderna Inc, which values the company at $ B. Is Moderna stock a Buy, Sell or Hold? Moderna stock has received. Moderna (MRNA) reported Q2 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Moderna's earnings per.
Moderna Inc. ; Ask. ; Ask Size. ; Exchange. NGS. NASD: MRNA · Price. $ · Volume. 3,, · Change. · % Change. % · Today's Open. $ · Previous Close. $ · Intraday High. $ · Intraday Low. Moderna Inc. · AT CLOSE PM EDT 08/28/24 · USD · % · Volume3,, Moderna (NASDAQ: MRNA) · Moderna Return vs. S&P · Moderna Company Info · News & Analysis · Valuation · Podcast Episodes · Earnings Transcripts · Related Stocks · NASDAQ. Previous close. The last closing price. $ ; Day range. The range between the high and low prices over the past day. $ - $ ; Year range. The range. Moderna reports second quarter financial results and provides business updates. Reports second quarter revenues of $ million, GAAP net loss of $ Today Moderna, Inc. has the market capitalization of B, it has increased by % over the last week. Does Moderna, Inc. Moderna Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, M ; Market Value, $B. The Moderna EPS is What Is the Next Moderna Earnings Date? Moderna will release its next earnings report.
Company profile page for Moderna Inc including stock price, company news, executives, board members, and contact information. Discover real-time Moderna, Inc. Common Stock (MRNA) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. A high-level overview of Moderna, Inc. (MRNA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment. Real-time Price Updates for Moderna Inc (MRNA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. According to 14 analysts, the average rating for MRNA stock is "Buy." The month stock price forecast is $, which is an increase of % from the.